Neural tissue mapping resolves pancreatic cancer spectral differences
Source check: Source checked. Not independent scientific confirmation.
Finding: Convolutional networks assigned Raman spectra to cellular regions in pancreatic tumor tissue from 15 patients. Region-specific analysis suggested different nuclear protein structures in conventional ductal cancer and intraductal papillary mucinous carcinoma, helping separate signals obscured in whole-tissue measurements. These are exploratory spectroscopic interpretations, without direct confirmation of particular protein identities, causal mechanisms or patient-level diagnostic accuracy.
Technology: One-dimensional convolutional neural network; shallow neural network
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- A CNN assigns spectra to tumor-type-specific nuclear and cytoplasmic regions, enabling subsequent region-specific interpretation of measured Raman bands.
- Test and result
- New tissue Raman measurements from 16 slides representing 15 patients, learned subcellular spectrum assignment, and region-specific spectral comparisons.
- Limitation / still unknown
- Independent biological confirmation and clinical diagnostic utility remain unestablished; internal spectrum-level splitting and augmentation do not establish independent patient-level performance.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10684650/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.